Chen Li-Hsien, Tang Sheau-Chung, Yang Shu-Er, Kao Erl-Shyh
Department of Food Science, Tunghai University, Taichung 407224, Taiwan.
Department of Nursing, National Taichung University of Science and Technology, Taichung 403027, Taiwan.
Int J Med Sci. 2025 Jul 28;22(14):3556-3564. doi: 10.7150/ijms.112103. eCollection 2025.
Sepsis caused by bacterial infection can also induce vascular endothelial damage through endotoxins secreted by bacteria such as lipopolysaccharides (LPS). The mechanism of LPS induce vascular endothelial damage is mainly through the release of pro-inflammatory factors and activation of matrix metalloproteinases (MMPs), then MMPs further cause the glycocalyx layer to damage endothelial cells and finally lead to hyperosmolar vascular abnormalities and eventually microcirculatory disorders in general clinical practice, and are used in clinical treatment to prevent the release of pro-inflammatory factors. However, the immunosuppressive effect of high-dose dexamethasone is unpredictable before pathogens are cleared. (CW) is a traditional Chinese medicine containing the biologically active ingredient β-elemene, which has been reported to have endothelial protective effects. In this study, an acute vascular endothelial damage animal model was established by intraperitoneal injection of LPS in rats, and the treatments included oral administration of CW root aqueous extract solution at a low dose (LW group, 375 mg/kg/day) and high dose (HW group, 1500 mg/kg) for endothelial protection evaluation. The results demonstrated that HW reduced the TLR4 signaling pathway and downstream markers of vascular inflammation, particularly MMP2 and MMP9. This study suggests that CW, a traditional Chinese medicine, could CW root aqueous extracts treatments protect against LPS-induced acute vascular damage in rats. This study advocates for further clinical exploration of CW as a potential clinical use in bacterial infection-induced sepsis or complementary treatment to current therapies, potentially benefiting cardiovascular and other inflammatory conditions.
细菌感染引起的脓毒症也可通过细菌分泌的内毒素如脂多糖(LPS)诱导血管内皮损伤。LPS诱导血管内皮损伤的机制主要是通过释放促炎因子和激活基质金属蛋白酶(MMPs),然后MMPs进一步导致糖萼层损伤内皮细胞,最终导致高渗性血管异常并最终导致微循环障碍,在一般临床实践中,用于临床治疗以防止促炎因子的释放。然而,在病原体清除之前,高剂量地塞米松的免疫抑制作用是不可预测的。(CW)是一种含有生物活性成分β-榄香烯的中药,据报道具有内皮保护作用。在本研究中,通过腹腔注射LPS在大鼠中建立急性血管内皮损伤动物模型,治疗包括口服低剂量(LW组,375mg/kg/天)和高剂量(HW组,1500mg/kg)的CW根水提取液以评估内皮保护作用。结果表明,HW降低了TLR4信号通路和血管炎症的下游标志物,特别是MMP2和MMP9。本研究表明,中药CW的根水提取物治疗可保护大鼠免受LPS诱导的急性血管损伤。本研究主张进一步临床探索CW作为细菌感染诱导的脓毒症的潜在临床用途或作为当前疗法的辅助治疗,可能有益于心血管和其他炎症性疾病。